Japanese Journal of Ophthalmology

, Volume 50, Issue 2, pp 170–175 | Cite as

Low Conversion Rate to Multiple Sclerosis in Idiopathic Optic Neuritis Patients in Taiwan

  • Yen-Ching Lin
  • May-Yung Yen
  • Wen-Ming Hsu
  • Hui-Chen Lee
  • An-Guor Wang
CLINICAL INVESTIGATION

Abstract

Purpose

To investigate the clinical characteristics of patients with idiopathic optic neuritis (ON) in Taiwan and to assess the conversion rate to multiple sclerosis (MS) in these patients.

Methods

We studied the medical records of a total of 109 patients with a clinical diagnosis of idiopathic ON treated in the Taipei Veterans General Hospital during the period from January 1986 to May 2003. Clinical characteristics, management, and disease courses were retrospectively reviewed. Our main focus was on the development of multiple sclerosis after an ON attack. Univariate and multivariate analyses were used to evaluate the risk indicators for MS conversion.

Results

The patients (58 women, 51 men) had a mean age of 41.2 years at onset. ON was retrobulbar in 46.8% of the patients. Management with or without pulse therapy did not affect the final visual outcome. Female sex, retrobulbar type ON, recurrent cases, elevated cerebrospinal fluid (CSF) IgG index, and central nervous system (CNS) imaging abnormalities were identified as risk indicators for the development of MS (P < 0.05). The 2-year cumulative probability of developing MS was 5.92%, and the 5-year cumulative probability was 14.28%. The conversion rate to MS did not differ among treatment groups.

Conclusions

Idiopathic ON patients in Taiwan have an older age at onset and a higher percentage of optic disc edema than reported in previous literature. The characteristic features of ON patients associated with a high risk of developing MS are female sex, retrobulbar type ON, CNS imaging abnormalities, elevated CSF IgG index, and recurrence. Idiopathic ON patients in Taiwan display a significantly lower conversion rate to MS. Jpn J Ophthalmol 2006;50:170–175 © Japanese Ophthalmological Society 2006

Key words

multiple sclerosis optic neuritis 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Perkin, GD, Rose, CF 1979Optic neuritis and its differential diagnosisOxford Medical PublicationsOxfordGoogle Scholar
  2. 2.
    Roy, WB 1998Optic neuritis. Walsh and Hoyt's clinical neuro-ophthalmology5th ed, Vol. 1.Williams & WilkinsBaltimore599639Google Scholar
  3. 3.
    Söderström, M 2001Review article: optic neuritis and multiple sclerosisActa Ophthalmol Scand79223227PubMedGoogle Scholar
  4. 4.
    Sandberg-Wollheim, M, Bynke, H, Cronqvist, S,  et al. 1990A long-term prospective study of optic neuritis: evaluation of risk factorsAnn Neurol27386393CrossRefPubMedGoogle Scholar
  5. 5.
    Rodriquez, M, Siva, A, Cross, SA,  et al. 1995Optic neuritis: a population-based study in Olmsted County, MinnesotaNeurology45244245Google Scholar
  6. 6.
    O'Riordan, JI, Thompson, AJ, Kingsley, DP,  et al. 1998The prognostic value of brain MRI in clinically isolated syndromes of the CNS. A 10-year follow-upBrain121495503CrossRefPubMedGoogle Scholar
  7. 7.
    Söderström, M, Ya-Ping, J, Hillert, J,  et al. 1998Optic neuritis. Prognosis for multiple sclerosis from MRI, CSF and HLA findingsNeurology50708714PubMedGoogle Scholar
  8. 8.
    Isayama, Y, Takahashi, T, Shimoyoma, T,  et al. 1982Acute optic neuritis and multiple sclerosisNeurology327376PubMedGoogle Scholar
  9. 9.
    Corona-Vazquez, T, Ruiz-Scadoval, J, Arriada-Mendicoa, N 1997Optic neuritis progression to multiple sclerosisActa Neurol Scand958589PubMedGoogle Scholar
  10. 10.
    Leary, SM, Miller, DH, Stevenson, VL,  et al. 2003Interferon beta-1a in primary progressive MS: an exploratory, randomized, controlled trialNeurology604451PubMedGoogle Scholar
  11. 11.
    Wingerchuk, DM, Noseworthy, JH 2002Randomized controlled trials to assess therapies for multiple sclerosisNeurology58S40S48PubMedGoogle Scholar
  12. 12.
    Beck, RW, Arrington, FR, Murtagh, J,  et al. 1993Brain magnetic resonance imaging in acute optic neuritis. Experience of the Optic Neuritis Study GroupArch Neurol50841846PubMedGoogle Scholar
  13. 13.
    Beck, RW, Cleary, PA 1993Optic Neuritis Treatment Trial: one-year follow-up resultsArch Ophthalmol111773775PubMedGoogle Scholar
  14. 14.
    Poser, CM, Paty, DW, Scheinberg, L,  et al. 1983New diagnostic criteria for multiple sclerosis: guidelines for research protocolsAnn Neurol13227231PubMedGoogle Scholar
  15. 15.
    Alter, M, Good, J, Okihiro, M 1973Optic neuritis in Orientals and CaucasiansNeurology23631639PubMedGoogle Scholar
  16. 16.
    Beck, RW Cleary, PA Trobe, JD and the Optic Neuritis Study Group et al. 1993The effect of corticosteroids for acute optic neuritis on the subsequent development of multiple sclerosisN Engl J Med32917641769CrossRefPubMedGoogle Scholar
  17. 17.
    Optic Neuritis Study Group1991The clinical profile of acute optic neuritis: experience of the Optic Neuritis Treatment TrialArch Ophthalmol10916731678Google Scholar
  18. 18.
    Hely, MA, McManis, PG, Doran, TJ,  et al. 1986Acute optic neuritis: a prospective study of risk factors for multiple sclerosisJ Neurol Neurosurg Psychiatry4911251130PubMedGoogle Scholar
  19. 19.
    The Optic Neuritis Study Group1997The 5-year risk of MS after optic neuritis: experience of the Optic Neuritis Treatment TrialNeurology4914041413Google Scholar
  20. 20.
    Jacobs, LD, Kaba, SE, Miller, CM,  et al. 1997Correlation of clinical, magnetic resonance imaging, and cerebrospinal fluid findings in optic neuritisAnn Neurol41392398PubMedGoogle Scholar
  21. 21.
    Frederiksen, JL, Petrera, J 1999Serial visual evoked potentials in 90 untreated patients with acute optic neuritisSurv Ophthalmol44S54S62PubMedGoogle Scholar
  22. 22.
    Morrissey, SP, Miller, DH, Kendall, BE,  et al. 1993The significance of brain magnetic resonance imaging abnormalities at presentation with clinical isolated syndromes suggestive of multiple sclerosisBrain116135146PubMedGoogle Scholar
  23. 23.
    Phillips, PH, Newman, NJ, Lynn, MJ 1998Optic neuritis in African-AmericansArch Neurol55186192CrossRefPubMedGoogle Scholar
  24. 24.
    Nakashima, I, Fujihara, K, Mitsu, T,  et al. 2001Epidemiology and clinical features of optico-spinal form multiple sclerosis in Japan (in Japanese)No To Shinkei (Brain and Nerve)53911917Google Scholar
  25. 25.
    Frederiksen, JL, Larsson, HBW, Oleson, J 1992Correlation of magnetic resonance imaging and CSF findings in patients with acute monosymptomatic optic neuritisActa Neurol Scand86317322PubMedGoogle Scholar
  26. 26.
    Rolak, LA Beck, RW Paty, DW and the Optic Neuritis Study Group et al. 1996Cerebrospinal fluid in acute optic neuritis: experience of the Optic Neuritis Treatment TrialNeurology46368372PubMedGoogle Scholar
  27. 27.
    Beck, RW, Cleary, PA, Anderson, MM,Jr,  et al. 1992A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritisN Engl J Med326581588PubMedGoogle Scholar
  28. 28.
    Wakakura, M, Mashimo, K, Oono, S,  et al. 1999Multicenter clinical trial for evaluating methylprednisolone pulse treatment of idiopathic optic neuritis in JapanJpn J Ophthalmol43133138PubMedGoogle Scholar
  29. 29.
    The Optic Neuritis Study Group1997Visual function 5 years after optic neuritis: experience of the Optic Neuritis Treatment TrialArch Ophthalmol11515451552Google Scholar

Copyright information

© Japanese Ophthalmological Society 2006

Authors and Affiliations

  • Yen-Ching Lin
    • 1
    • 2
  • May-Yung Yen
    • 1
    • 2
  • Wen-Ming Hsu
    • 1
    • 2
  • Hui-Chen Lee
    • 3
  • An-Guor Wang
    • 1
    • 2
  1. 1.Department of OphthalmologyTaipei Veterans General HospitalTaipeiTaiwan
  2. 2.School of MedicineNational Yang-Ming UniversityTaipeiTaiwan
  3. 3.Division of Experimental SurgeryTaipei Veterans General HospitalTaipeiTaiwan

Personalised recommendations